WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Open this folder and view contentsBullous dermatoses
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Close this folderAntimicrobial drugs
View the documentAciclovir
View the documentBenzylpenicillin
View the documentClioquinol
View the documentErythromycin
View the documentMethylrosanilinium chloride (gentian violet)
View the documentNeomycin + bacitracin
View the documentTetracycline
View the documentTiabendazole
Open this folder and view contentsAntifugal drugs
Open this folder and view contentsAntiseptic agents
Open this folder and view contentsKeratoplastic and keratolytic agents
Open this folder and view contentsScabicides and pediculicides
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Open this folder and view contentsUltraviolet radiation-blocking agents (sunscreens)
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

Neomycin + bacitracin

Ointment, 5 mg of neomycin sulfate + 500 IU of bacitracin zinc/g

General information

A topical broad-spectrum antibiotic.

Clinical information

Uses

Treatment of superficial bacterial infections of the skin due to staphylococci and streptococci.

Dosage and administration

Adults and children: a thin layer of ointment should be applied to the affected skin three times daily until symptoms have resolved.

Contraindications

Known hypersensitivity to bacitracin or neomycin.

Precautions

Neomycin + bacitracin ointment should not be applied to large areas of burned or broken skin, since significant systemic absorption can occur, which may lead to irreversible ototoxicity and renal damage.

Adverse effects

Sensitization, especially to neomycin, may occur with continued or repeated use, causing reddening and scaling of the treated area. Prolonged use may result in overgrowth of non-susceptible organisms.

Anaphylactic reactions are rare.

Storage

The ointment should be stored, protected from light and moisture, below 25 °C.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019